Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Item 9 Labs Corp. (INLB : OTC)

• Company Description    Item 9 Labs Corp. is a vertically integrated cannabis operator delivering premium products from its large-scale cultivation and production facilities in the United States. Item 9 Labs Corp. is based in PHOENIX. Number of Employees: 105

• Price / Volume Information    Yesterday's Closing Price: $0.93 Daily Weekly Monthly 20 Day Moving Average: 17,244 shares Shares Outstanding: 94.95 (millions) Market Capitalization: $88.30 (millions) Beta: 1.19 52 Week High: $3.74 52 Week Low: $0.83 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -16.96% -6.49% 12 Week -19.83% -11.87% Year To Date -16.22% 7.88%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2727 NORTH 3RD STREET SUITE 201 - PHOENIX,AZ 85004 USA ph: 833-867-6337 fax: - investors@item9labs.com http://www.item9labscorp.com

• General Corporate Information    Officers Andrew Bowden - Chief Executive Officer and Director Douglas Bowden - Chairman of the Board Chris Wolven - Chief Operating Officer Robert Mikkelsen - Chief Financial Officer Ronald L. Miller - Director Peer Information Item 9 Labs Corp. (BJCT) Item 9 Labs Corp. (CADMQ) Item 9 Labs Corp. (APNO) Item 9 Labs Corp. (UPDC) Item 9 Labs Corp. (IMTIQ) Item 9 Labs Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 46564C203 SIC: 3843 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/15/22 Share - Related Items Shares Outstanding: 94.95 Most Recent Split Date: 10.00 (0.05:1) Beta: 1.19 Market Capitalization: $88.30 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/15/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.07 Price/Cash Flow: - Price / Sales: 3.45 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 8.62% vs. Previous Quarter: 7.31% ROE 03/31/22 - -17.59 12/31/21 - -11.86 09/30/21 - -11.69 ROA 03/31/22 - -13.56 12/31/21 - -9.82 09/30/21 - -9.78 Current Ratio 03/31/22 - 0.19 12/31/21 - 0.53 09/30/21 - 0.71 Quick Ratio 03/31/22 - - 12/31/21 - 0.20 09/30/21 - 0.28 Operating Margin 03/31/22 - -66.78 12/31/21 - -52.53 09/30/21 - -49.71 Net Margin 03/31/22 - -66.78 12/31/21 - -52.53 09/30/21 - -49.71 Pre-Tax Margin 03/31/22 - -66.75 12/31/21 - -52.53 09/30/21 - -49.72 Book Value 03/31/22 - 0.87 12/31/21 - 0.89 09/30/21 - 0.94 Inventory Turnover 03/31/22 - 3.97 12/31/21 - 5.33 09/30/21 - 8.34 Debt-to-Equity 03/31/22 - 0.02 12/31/21 - 0.19 09/30/21 - 0.17 Debt-to-Capital 03/31/22 - 1.95 12/31/21 - 16.15 09/30/21 - 14.80

Powered by Zacks Investment Research ©